HYDI Hydromer Inc. featured news, full reports, and detailed charts
Hydromer Inc. (HYDI/HYDI.OB) Wrap Up:
Hydromer, Inc., a bio-polymer research and development company, engages in the research, development, manufacture, and commercialization of specialized polymer and hydrogel products for medical device, pharmaceutical, animal health, cosmetic, personal care, and industrial uses in the United States and internationally. The company owns patents for Hydromer coatings, which are used in materials, such as polyurethane, polyvinyl chloride, and silicone elastomers; ceramics; and metals. It also has patents for permanent anti-fog materials, hydrophilic polyurethane foams, hydrophilic polyurethane blends, hydrophilic polyvinylbutyral alloys, various biocompatible hydrogels, and an anti-bacterial med...Hydromer Inc. (HYDI:OTC Bulletin Board Market)
Snapshot of Hydromer Inc. (HYDI)
|
OPEN
$0.41
|
PREVIOUS CLOSE
$0.90
|
|
|
DAY HIGH
$0.75
|
DAY LOW
$0.41
|
|
|
52 WEEK HIGH
11/26/08 - $1.49
|
52 WEEK LOW
02/27/09 - $0.25
|
|
|
MARKET CAP
3.5M
|
AVERAGE VOLUME 3 mo
2.2K
|
|
|
DILUTED EPS TTM
$0.04
|
SHARES OUTSTANDING
4.8M
|
|
|
HYDI Does Not Pay Dividends
|
P/E TTM
18.7x
|
|
| K = Thousands M = Millions B = Billions | ||
HYDI Top Compensated Officers
Executives, Board Directors
Key developments for Hydromer Inc. (HYDI)
Hydromer Inc., Annual General Meeting, Nov 18, 2009, at 10:00 Eastern Daylight. Location: 35 Industrial Parkway, Branchburg, NJ 08876, United States. Agenda: To elect eight directors of the company for the ensuing year; to ratify the selection by the board of directors of Rosenberg Rich Baker Berman & Company as the company's independent public accountants for fiscal 2010; and to transact such other business as may properly come before the meeting or any adjournment thereof.
NASDAQ OMX BX announced that it will file a Form 25 with the Securities and Exchange Commission to delist the common stock of Hydromer Inc. The delisting will become effective ten days after the Form 25 is filed. NASDAQ OMX BX is taking this step in connection with the termination of its listing program, which was announced in October 2007.
Hydromer Inc. reported earnings results for the quarter ended March 31, 2009. For the period, the company reported net income of $519,803 compared to net income of $44,122 for the same quarter in the previous year.
HYDI Competitors
| Company | Last | Change |
| Biosensors International Group Ltd | $0.72 SGD | 0.00 |
| Durect Corp | $2.09 USD | -0.02 |
| pSivida Corp | $4.09 USD | +0.08 |
| QLT Inc | C$3.91 CAD | -0.04 |
| SurModics Inc | $22.92 USD | +0.14 |
| Market data is delayed at least 20 minutes. | ||
Industry Analysis
| Valuation | HYDI | Industry Range |
| Price/Earnings | 8.5x |
|
| Price/Sales | 0.6x |
|
| Price/Book | 1.1x |
|
| Price/Cash Flow | 8.5x |
|
| TEV/Sales | NM | Not Meaningful |
|
HYDI |
||